Gabapentin extended-release - Depomed: Gabapentin ER, gabapentin gastric retention, gapapentin GR

Drugs in R and D

Volumn 8, Issue 5, 2007, Pages 317-320

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PLACEBO;

ANALGESIC ACTIVITY; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DIABETIC NEUROPATHY; DIZZINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG INDICATION; DRUG MECHANISM; DRUG WITHDRAWAL; EPILEPSY; HOT FLUSH; HUMAN; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; TABLET FORMULATION;

AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; DELAYED-ACTION PREPARATIONS; DIABETIC NEUROPATHIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; PAIN;

EID: 34548645161     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200708050-00005     Document Type: Review

References (11)

1. Depomed Inc. Depomed Acquires Exclusive Rights to Gabapentin GR. Media Release: 22 Sep 2003. Available from URL: http://www.depomedinc.com
2. Depomed Inc. Depomed and Elan Enter into Termination Agreement. Media Release: 22 Sep 2003. Available from URL: http://www.depomedinc.com
3. Depomed Inc. Depomed Acquires Remaining Interest in Majority-Owned Subsidiary. Media Release: 7 Jun 2004. Available from URL: http://www. depomedinc.com
4. Depomed Inc. Depomed Obtains Exclusive License to Gabapentin Use in Hot Flashes. Media Release: 18 Oct 2006. Available from URL: http://www.depomedinc. com
5. Depomed Inc. Depomed Reports Dose Proportionality of Gabapentin GR at the Endocrine Society's Annual Meeting. Media Release: 26 Jun 2006. Available from URL: http://www.depomedinc.com
6. Depomed Inc. Depomed Completes Enrollment for Phase II Clinical Trial for Gabapentin GR(TM). Media Release: 24 Oct 2005. Available from URL: http://www.depomedinc.com
7. Depomed Inc. Depomed Reports Second Quarter 2006 Financial Results; Revenues Increase to $2.2 Million Compared to $428,000 in 2005. Media Release: 7 Aug 2006. Available from URL: http://www.depomedinc.com
8. Depomed Inc. Depomed Expands Patent Portfolio for Drug Delivery Technology. Media Release: 11 May 2004. Available from URL: http://www. depomedinc.com
9. Depomed Inc. Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR™ In Postherpetic Neuralgia. Media Release: 10 Jul 2007. Available from URL: http://www.depomedinc.com
10. Depomed Inc. Depomed Announces Positive Results of Phase II Clinical Trial for Gabapentin GR(TM) in Postherpetic Neuralgia. Media Release: 4 Jan 2006. Available from URL: http://www.depomedinc.com
11. Depomed Inc. Depomed Announces Strong Positive Phase II Trial Results for Once Daily Gabapentin GR™ to Treat Symptoms of Diabetic Peripheral Neuropathy. Media Release: 13 Dec 2006. Available from URL: http://www. depomedinc.com